Additionally, Yue et al. uncovered a Wnt-independent LGR4-EGFR signaling axis enhancing breast cancer cell metastasis with broad implications for the targeted therapy of breast cancer (Yue et al., 2021). This evidence concerns the gene EGFR and breast carcinoma.